PROCEPT BioRobotics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $172,500,000.00 in Post-IPO Equity.
According to filings with the U.S. Securities and Exchange Commission, PROCEPT BioRobotics is raising $172,500,000.00 in new funding. About PROCEPT BioRobotics: PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
To learn more about PROCEPT BioRobotics, visit http://www.procept-biorobotics.com/
Contact:
Reza Zadno, President and Chief Executive Officer
650-232-7200
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.